Maricuto, Andrea L. published the artcileAmoebic liver abscess in a COVID-19 patient: a case report, Related Products of esters-buliding-blocks, the main research area is amoebic liver abscess COVID19; Amoebic liver abscess; COVID-19; Case report; Entamoeba histolytica; SARS-CoV-2; Venezuela.
Amoebiasis is a parasitic disease caused by Entamoeba histolytica, which affects people living in low- and middle-income countries and has intestinal and extraintestinal manifestations. To date, knowledge on coronavirus disease 2019 (COVID-19) coinfection with enteric parasites is limited, and E. histolytica coinfection has not been previously described. Here we present the case of a patient with COVID-19 who, during hospitalisation, presented a clin. picture consistent with an amoebic liver abscess (ALA). Case presentation: A 54-yr-old man, admitted as a suspected case of COVID-19, presented to our hospital with dyspnoea, malaise, fever and hypoxemia. A nasopharyngeal swab was pos. for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by reverse-transcription polymerase chain reaction. After 7 days, he developed diarrhoea, choluria and dysentery. An abdominal ultrasound showed a lesion compatible with a liver abscess; stool examination revealed E. histolytica trophozoites, and addnl. serol. for E. histolytica was pos. After 12 days of treatment with metronidazole, ceftazidime and nitazoxanide, the patient reported acute abdominal pain, and an ultrasound examination revealed free liquid in the abdominal cavity. An emergency exploratory laparotomy was performed, finding 3000 mL of a thick fluid described as “”anchovy paste””. Computed tomog. scan revealed a second abscess. He ended up receiving 21 days of antibiotic treatment and was discharged with satisfactory improvement. Conclusion: Here we present, to the best of our knowledge, the first report of ALA and COVID-19 co-presenting. Based on their pathophysiol. similarities, coinfection with SARS-CoV-2 and E. histolytica could change the patient’s clin. course; however, larger studies are needed to fully understand the interaction between these pathogens.
BMC Infectious Diseases published new progress about Antibiotics. 55981-09-4 belongs to class esters-buliding-blocks, name is 2-((5-Nitrothiazol-2-yl)carbamoyl)phenyl acetate, and the molecular formula is C12H9N3O5S, Related Products of esters-buliding-blocks.
Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics